Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Total Liabilities
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd total liabilities. Based on the latest financial reports, Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has total liabilities worth CN¥4.79 Billion CNY (≈ $700.86 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Hunan Dajiaweikang Pharmaceutical Indust (301126) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
Total liabilities of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025. This chart illustrates how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's total liabilities have evolved over time, based on quarterly financial data.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Liaoning SG Automotive Group Co Ltd
SHG:600303
|
China | CN¥2.21 Billion |
|
Shenzhen Sine Electric Co. Ltd. A
SHG:688395
|
China | CN¥164.89 Million |
|
Rongyu Group Co Ltd
SHE:002622
|
China | CN¥1.04 Billion |
|
Sonda S.A
SN:SONDA
|
Chile | CL$873.83 Billion |
|
8x8 Inc Common Stock
NASDAQ:EGHT
|
USA | $524.99 Million |
|
Oxley Bridge Acquisition Limited Class A Ordinary Shares
NASDAQ:OBA
|
USA | $8.60 Million |
|
Pioneer Acquisition I Corp Class A Ordinary Shares
NASDAQ:PACH
|
USA | $12.19 Million |
|
Hengxin Mobile Business
SHE:300081
|
China | CN¥977.43 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Hunan Dajiaweikang Pharmaceutical Indust (301126) total assets.
Liquidity & Leverage Metrics
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Total Liabilities Ratios Explained
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
The table below shows the annual total liabilities of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥4.74 Billion ≈ $694.20 Million |
+9.57% |
| 2024-12-31 | CN¥4.33 Billion ≈ $633.54 Million |
+23.84% |
| 2023-12-31 | CN¥3.50 Billion ≈ $511.58 Million |
+65.36% |
| 2022-12-31 | CN¥2.11 Billion ≈ $309.37 Million |
+60.76% |
| 2021-12-31 | CN¥1.32 Billion ≈ $192.45 Million |
+13.33% |
| 2020-12-31 | CN¥1.16 Billion ≈ $169.82 Million |
+11.82% |
| 2019-12-31 | CN¥1.04 Billion ≈ $151.86 Million |
-- |
About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages… Read more